Breast Cancer Research

official impact factor 5.79

This article is part of the supplement: Breast cancer research: the past and the future

Email this article to a friend

Benefits of combined treatments using antiresorptive agents and cytotoxic drugs

I Holen, H Neville-Webbe and RE Coleman

Breast Cancer Research 2006, 8(Suppl 2):S12 doi:10.1186/bcr1555

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.